Articles Referencing BTX

Zacks.com

Lower Loss at Geron - Analyst Blog

Geron Corporation ( GERN ) posted a net loss of 10 cents per share in the fourth quarter of 2012, narrower than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of... Read >>

Zacks.com

Geron's Update on Stem Cell Assets - Analyst Blog

Geron Corporation ( GERN ) announced that it has signed an Asset Contribution Agreement with BioTime, Inc. ( BTX ) and BioTime's recently formed subsidiary, BioTime... Read >>

Kapitall

Stem Cell Therapy May Prevent Heart Failure: 4 Companies to Watch

( Written by Alexander Crawford. Data sourced from Finviz.) A stem cell treatment for heart disease from Australia’s biotech firm Mesoblast Ltd lowered the risk of heart attack or cardiac... Read >>

Kapitall

30 Small Caps Snapped By Smart Money

The following is a list of small cap stocks, with market caps between $300M-$500M.  All of these companies have seen significant institutional and mutual fund buying over the last three... Read >>